pyrimidine has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begué-Pastor, N; Benavent, S; Burger, D; Chicheportiche, R; Dayer, JM; Gruaz, L; Kaufmann, MT | 1 |
| Dingledine, R; Ganesh, T; Jiang, J; Van, TM | 1 |
2 other study(ies) available for pyrimidine and dinoprostone
| Article | Year |
|---|---|
The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes.
Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Rheumatoid; Cells, Cultured; Crotonates; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydroxybutyrates; Interleukin-6; Isoenzymes; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Membrane Proteins; Nitriles; Prostaglandin-Endoperoxide Synthases; Pyrimidines; RNA, Messenger; Synovial Membrane; Toluidines; Uridine | 2003 |
Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2.
Topics: Benzamides; Cyclic AMP; Dinoprostone; Humans; Neurons; Pyrimidines; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype | 2018 |